⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EXOZ News
eXoZymes Inc. Common Stock
Form 8-K
sec.gov
EXOZ
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
accessnewswire.com
EXOZ
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
accessnewswire.com
EXOZ
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
accessnewswire.com
EXOZ
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
accessnewswire.com
EXOZ
eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run
accessnewswire.com
EXOZ
eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion
accessnewswire.com
EXOZ
eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion
accessnewswire.com
EXOZ
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
accessnewswire.com
EXOZ
eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff
accessnewswire.com
EXOZ